Tackling the Serious Global Challenges in Infectious Disease

Appili was created to deliver innovative drug development programs for unmet patient needs across a broad spectrum of infectious diseases

Appili Therapeutics Infectiou Disease Drug Development Program

Advancing infectious disease drug development programs to provide solutions to patients, doctors, and society.

Leadership team skilled in advancing programs with upside potential

Active partnering and in-licensing efforts to expand clinical programs and accelerate commercialization

Appili Therapeutics: Innovation Across a Broad Spectrum of Anti-Infectives

LATEST NEWS & EVENTS

Appili Therapeutics Reports Fiscal Year 2022 Financial and Operational Results
06/29/20222
Appili Therapeutics Announces Closing of Public Offering of $4,500,000
05/26/2022
Appili Therapeutics Announces Pricing of Overnight Marketed Equity Offering
05/18/2022